Keystone Symposium

June 18th, 2019 – Keystone, CO, USA

Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA.

News & Events:

New CEO of Priavoid

2. September 2020

Office establishment

6. März 2020

BIO-EUROPE SPRING 2020

3. März 2020

Seed Investment

6. Mai 2019

Prof. Willbold´s interview with PharmaVentures

23. Januar 2018

Clinical trial with PRI-002

31. Mai 2017